Latest News and Press Releases

More than 92% of schizophrenia patients taking TEV-'749 in the SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication1New data from UZEDY®...

REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines...

Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn’s disease and ulcerative colitisThe FDA previously approved...

The expansion of the strategic partnership reinforces the solid foundation of the collaborative efforts that commenced in April 2024The collaboration supports Teva's Pivot to Growth strategy and adds...

NurExone Welcomes Biopharma Executive Dr. Ram Petter to Drive Strategic Collaborations

More than $350,000 of Convertible Debt Eliminated BOCA RATON, FL, April 13, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group (OTC PINK: CTYX) has filed all required annual reports...

PHILADELPHIA, June 24, 2019 (GLOBE NEWSWIRE) -- A lawsuit was filed on June 20, 2019 in Montgomery County, Pennsylvania against Teva Pharmaceuticals USA, Inc. and Teva Branded Pharmaceuticals...

PHILADELPHIA, Nov. 20, 2018 (GLOBE NEWSWIRE) -- A unanimous jury in Philadelphia federal court found in favor of Stephen Middlebrooks and concluded that he was retaliated against and subject to a...

- Reverse stock split to be effective on Wednesday, January 24, 2018 on split-adjusted basis under trading symbol “COCPD” - ATLANTA, GA and BOTHELL, WA, Jan. 23, 2018 (GLOBE NEWSWIRE) --...

– Reverse stock split positions Company to uplist to the NASDAQ Capital Market in Q1 2018 – – Company expects to commence Phase 2a study in Q1 2018 for lead program, CC-31244, for the treatment of...